TIDMMPH

RNS Number : 5578V

Mereo BioPharma Group plc

03 December 2019

Mereo BioPharma Group plc

("Mereo" or the "Company")

Notification of PDMR Dealing

London, December 03, 2019 - Mereo BioPharma Group plc (AIM: MPH, NASDAQ: MREO), a clinical stage UK based biopharmaceutical company focused on rare diseases, received notification that on December 02, 2019, John Richard, Head of Corporate Development, purchased 3500 American Depositary Shares (ADSs) at an aggregated price of USD 2.201 per ADS.

The below announcement and notification is made in accordance with the EU Market Abuse Regulation. The form required under the EU Market Abuse Regulation follows.

 
 1    Details of the person discharging managerial responsibilities 
 a)   Name                      John Richard 
     ------------------------  -------------------------------------------------- 
 2    Reason for the notification 
     ---------------------------------------------------------------------------- 
 a)   Position/status           Head of Corporate Development 
     ------------------------  -------------------------------------------------- 
 b)   Initial notification/     Initial notification 
       Amendment 
     ------------------------  -------------------------------------------------- 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     ---------------------------------------------------------------------------- 
 a)   Name                      Mereo BioPharma Group plc 
     ------------------------  -------------------------------------------------- 
 b)   LEI                       213800U8JQHIJOS5AS09 
     ------------------------  -------------------------------------------------- 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
     ---------------------------------------------------------------------------- 
 a)   Description of            AMERICAN DEPOSITARY SHARE (ADS) EACH REPRESENTING 
       the financial             5 MEREO BIOPHARMA GROUP PLC ORDINARY SHARES 
       instrument, type          OF GBP0.003 EACH 
       of instrument 
       and identification 
       code 
     ------------------------  -------------------------------------------------- 
 b)   Nature of the             PURCHASE OF ADS 
       transaction 
     ------------------------  -------------------------------------------------- 
 c)   Price(s) and                Price(s)    Volume(s) 
       volume(s)                   USD 2.25    400 
                                   USD 2.20    2269 
                                   USD 2.19    547 
                                   USD 2.19    100 
                                   USD 2.18    1 
                                   USD 2.16    1 
                                   USD 2.15    182 
                                              ---------- 
     ------------------------  -------------------------------------------------- 
 d)   Aggregated information:   Aggregated volume: 3500 
       volume, Price             Aggregated price: USD2.201 
     ------------------------  -------------------------------------------------- 
 e)   Date of the transaction   2019-12-02 
     ------------------------  -------------------------------------------------- 
 f)   Place of the              XNMS 
       transaction 
     ------------------------  --------------------------------------------------

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHBLBDDXUGBGCX

(END) Dow Jones Newswires

December 03, 2019 11:54 ET (16:54 GMT)

Mereo Biopharma (LSE:MPH)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025 Click aqui para mais gráficos Mereo Biopharma.
Mereo Biopharma (LSE:MPH)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025 Click aqui para mais gráficos Mereo Biopharma.